Literature DB >> 7355388

Gentamicin dosage requirements: wide interpatient variations in 242 surgery patients with normal renal function.

D E Zaske, R J Cipolle, R J Strate.   

Abstract

Wide interpatient variations were demonstrated in gentamicin elimination rate and dosage requirements for 242 surgery patients with normal renal function. These patients' half-lives ranged from 0.4 to 13.4 hours as compared to previous reports of 2.5 to 4 hours. The distribution volumes ranged from 0.06 to 0.63 liter/kg, as compared of reported values of 0.20 to 0.25 liter/kg. These wide interpatient variations in kinetic parameters, combined with the need to obtain narrow ranges in serum concentrations, necessitated measuring serum concentrations and individually calculating each patient's dosage regimen early in the treatment course. Using this approach, optimal peak and trough serum levels were consistently produced in these patients. Their required dosage regimens demonstrated considerable variability--ranging from 0.7 to 12.4 mg/kg/day. Compared to the recommended regimen (3 to 5 mg/kg/day), 47% of these surgery patients required higher dosages, and 14% required lower dosages. The incidence of ototoxicity and nephrotoxicity were extremely low, with only three patients possibly having gentamicin-associated nephrotoxicity. These results further emphasize the need to measure serum concentrations and make necessary dosage adjustments to ensure therapeutic levels. However, because of the wide interpatient variation, these increased dosage regimens are not routinely suggested without previously measuring serum concentrations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7355388

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  25 in total

1.  Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections.

Authors:  J S Solomkin; E P Dellinger; N V Christou; R W Busuttil
Journal:  Ann Surg       Date:  1990-11       Impact factor: 12.969

2.  Changes in gentamicin pharmacokinetic profiles induced by mechanical ventilation.

Authors:  C Triginer; I Izquierdo; R Fernández; J Torrent; S Benito; A Net; F Jane
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients.

Authors:  Federico Pea; Federica Pavan; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

4.  Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units.

Authors:  K Vandewoude; D Vogelaers; J Decruyenaere; P Jaqmin; K De Beule; A Van Peer; R Woestenborghs; K Groen; F Colardyn
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

Review 5.  Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.

Authors:  Peter De Paepe; Frans M Belpaire; Walter A Buylaert
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

6.  Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit.

Authors:  J Albanèse; M Léone; B Bruguerolle; M L Ayem; B Lacarelle; C Martin
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

7.  Individualised aminoglycoside dosage based on pharmacokinetic analysis is superior to dosage based on physician intuition at achieving target plasma drug concentrations.

Authors:  E J Begg; H C Atkinson; G M Jeffery; N W Taylor
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

Review 8.  Once-daily aminoglycoside administration in gram-negative sepsis. Economic and practical aspects.

Authors:  S E Parker; P G Davey
Journal:  Pharmacoeconomics       Date:  1995-05       Impact factor: 4.981

Review 9.  Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.

Authors:  Federico Pea; Pierluigi Viale; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

10.  Amikacin and gentamicin accumulation pharmacokinetics and nephrotoxicity in critically ill patients.

Authors:  M A French; F B Cerra; M E Plaut; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.